The Cancer Genome Atlas (TCGA) cohorts reveal that ATM is the most frequently mutated DNA damage response gene in NSCLC, with mutation rates around 9% in LUAD and 4% in lung squamous cell carcinoma [13,14]. This evidence concerns the gene ATM and non-small cell lung carcinoma.